Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

Página do item simplificado
dc.citation.issue5
dc.citation.volume27
dc.contributor.authorEnsina, L. F. [UNIFESP]
dc.contributor.authorCusato-Ensina, A. P.
dc.contributor.authorCamelo-Nunes, I. C. [UNIFESP]
dc.contributor.authorSole, D. [UNIFESP]
dc.coverageBarcelona
dc.date.accessioned2020-07-17T14:03:28Z
dc.date.available2020-07-17T14:03:28Z
dc.date.issued2017
dc.description.affiliationUniv Fed Sao Paulo, Dept Pediat, Div Allergy Clin Immunol & Rheumatol, Sao Paulo, Brazil
dc.description.affiliationCPAlpha Clin Res, Barueri, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Dept Pediat, Div Allergy Clin Immunol & Rheumatol, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent326-327
dc.identifierhttp://dx.doi.org/10.18176/jiaci.0179
dc.identifier.citationJournal Of Investigational Allergology And Clinical Immunology. Barcelona, v. 27, n. 5, p. 326-327, 2017.
dc.identifier.doi10.18176/jiaci.0179
dc.identifier.issn1018-9068
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55425
dc.identifier.wosWOS:000416501500011
dc.language.isoeng
dc.publisherEsmon Publicidad S A, Dept Allergy
dc.relation.ispartofJournal Of Investigational Allergology And Clinical Immunology
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectUrticariaen
dc.subjectOmalizumaben
dc.subjectAngioedemaen
dc.subjectTherapeuticsen
dc.titleOmalizumab as Third-Line Therapy for Urticaria During Pregnancyen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Outras produções